Donate Toggle Menu

A major pharmaceutical manufacturer has commissioned market research to help improve its communications directed toward Renal Cell Carcinoma (RCC) patients.

Your participation in this research project can help ensure that the company’s website and other materials are relevant to patients’ concerns and expressed in a clear and comprehensible way.

Flince Research + Design, an independent healthcare research and consulting firm located in the U.S., has been engaged to conduct these research interviews on pharmaceutical manufacturer’s behalf.   The research project consists of a one-time telephone interview lasting 60 minutes.

The research project is open to patients, or caregivers of patients, who have Stage IV metastatic RCC and who have received at least one line of treatment beyond nephrectomy.  Please note that space is limited and the research project enrollment will be filled on a first-come, first-served basis.

The research will not require any special preparation by patients, and it will be conducted in strict accordance with all pertinent privacy laws and regulations, including maintaining participants’ confidentiality.

In appreciation of your time and valuable contribution, you will receive an honorarium of $200 payable upon successful completion of the telephone interview.

For more information on how you may participate in this important research project please contact:

Jason Turner

Field Director

Flince Research + Design

+1 773 383 9090

[email protected]